Literature DB >> 28832907

Complications in operative hysteroscopy - is prevention possible?

Mee Kristine Aas-Eng1, Anton Langebrekke1, Gernot Hudelist2.   

Abstract

Operative hysteroscopy in a hospital setting has revolutionized surgical treatment of benign uterine disorders. It is minimally invasive, cost- and time-effective, and may spare patients major surgical interventions. Operative hysteroscopy in a day-case hospital setting is regarded as a safe and well-tolerated procedure with low complication rates. However, prevention of adverse events is crucial in daily practice to optimize patient care. Complications in operative hysteroscopy can be divided into early complications, including bleeding, uterine perforation, infection and fluid overload, or late complications and suboptimal outcomes, such as incomplete resection and intrauterine adhesions. Awareness and knowledge of management of adverse events as well as the use of possible preventative measures will increase the quality and safety of hysteroscopic surgery. The present commentary focuses on these issues as an up-to-date basis for everyday clinical practice.
© 2017 Nordic Federation of Societies of Obstetrics and Gynecology.

Entities:  

Keywords:  Operative hysteroscopy; early complications; education; late complications; prevention; suboptimal outcomes

Mesh:

Year:  2017        PMID: 28832907     DOI: 10.1111/aogs.13209

Source DB:  PubMed          Journal:  Acta Obstet Gynecol Scand        ISSN: 0001-6349            Impact factor:   3.636


  2 in total

1.  Is every patient eligible to have an office hysteroscopy? A retrospective analysis of 1301 procedures.

Authors:  Magdalena M Biela; Jacek Doniec; Monika Szafarowska; Kamil Sobocinski; Andrzej Kwiatkowski; Paweł Kamiński
Journal:  Wideochir Inne Tech Maloinwazyjne       Date:  2019-11-05       Impact factor: 1.195

2.  Likelihood of Accomplishing an In-Patient Hysteroscopic Myomectomy in a One-Step Procedure: A Systematic Review and Meta-Analysis.

Authors:  Ugo Indraccolo; Vittorio Bini; Alessandro Favilli
Journal:  Biomed Res Int       Date:  2020-01-08       Impact factor: 3.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.